Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in...
22 insider purchases on record · latest filing 2025-11-18.
Insiders have also filed 157 sale transactions at PSNL.